FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

FOXP2 shares partially overlapping normal tissue expression and functionality with FOXP1; an established diffuse large B-cell lymphoma (DLBCL) oncogene and marker of poor prognosis. FOXP2 is expressed in the plasma cell malignancy multiple myeloma but has not been studied in DLBCL, where...

Full description

Bibliographic Details
Main Authors:	Wong, K, Gascoyne, D, Soilleux, E, Lyne, L, Spearman, H, Banham, A, Roncador, G, Pedersen, L, Moller, M, Green, T
Format:	Journal article
Published:	Impact Journals 2016

Similar Items

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
by: Brown, P, et al.
Published: (2015)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
by: Wong, K, et al.
Published: (2014)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
by: Wong, K, et al.
Published: (2014)

The significance of FOXP1 in diffuse large B-cell lymphoma
by: Gascoyne, D, et al.
Published: (2016)

Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
by: Gascoyne, D, et al.
Published: (2016)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
by: Banham, A, et al.
Published: (2008)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
by: Barrans, S, et al.
Published: (2004)

FOXP3 expression in B and T cell lymphomas.
by: Roncador, G, et al.
Published: (2005)

The NFIL3 transcription factor is preferentially expressed in BCR-independent mature B-cell malignancy
by: Gascoyne, D, et al.
Published: (2012)

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas
by: Loo, SK, et al.
Published: (2017)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
by: Camilleri, E, et al.
Published: (2012)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
by: Brown, P, et al.
Published: (2016)

TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma
by: Loo, S, et al.
Published: (2017)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
by: Banham, A, et al.
Published: (2005)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
by: Barrans, S, et al.
Published: (2005)

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.
by: Roncador, G, et al.
Published: (2005)

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.
by: Nyman, H, et al.
Published: (2009)

The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
by: Farinha, P, et al.
Published: (2006)

The architectural pattern of FOXP3*T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
by: Farinha, P, et al.
Published: (2006)

The forkhead transcription factor FOXP2 is required for regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest
by: Gascoyne, DM, et al.
Published: (2015)

Expression of FOXP2 is up-regulated in lymphoid malignancies
by: Campbell, A, et al.
Published: (2009)

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species.
by: Banham, A, et al.
Published: (2009)

CRISPR/Cas9-mediated Foxp1 silencing restores immune surveillance in an immunocompetent A20 lymphoma model
by: Felce, SL, et al.
Published: (2020)

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
by: Carreras, J, et al.
Published: (2006)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
by: Brown, P, et al.
Published: (2005)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
by: Barrans, S, et al.
Published: (2007)

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
by: Haralambieva, E, et al.
Published: (2006)

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
by: Copie-Bergman, C, et al.
Published: (2009)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
by: Nyman, H, et al.
Published: (2009)

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
by: Nyman, H, et al.
Published: (2008)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells.
by: Campbell, A, et al.
Published: (2010)

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.
by: Klemke, C, et al.
Published: (2006)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells: Research paper
by: Campbell, A, et al.
Published: (2010)

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
by: Fenton, J, et al.
Published: (2006)

Chopping a Chebyshev series
by: Aurentz, J, et al.
Published: (2016)

MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
by: Borovecki, A, et al.
Published: (2007)

FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
by: Goatly, A, et al.
Published: (2008)

FOXP1 abnormalities in lymphoma: Translocation breakpoint mapping reveals insights into deregulated transcriptional control
by: Goatly, A, et al.
Published: (2008)

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
by: Salerno-Gonçalves, R, et al.
Published: (2022)

Pathway activation patterns in diffuse large B-cell lymphomas.
by: Bentink, S, et al.
Published: (2008)